

Publisher: John Wiley & Sons Inc
E-ISSN: 1398-9995|70|6|707-710
ISSN: 0105-4538
Source: ALLERGY, Vol.70, Iss.6, 2015-06, pp. : 707-710
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


The Safety of Allergen Specific Sublingual Immunotherapy
Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. :




Clinical contraindications to allergen immunotherapy: an EAACI position paper
ALLERGY, Vol. 70, Iss. 8, 2015-08 ,pp. :


Requirement of MyD88 and Fas pathways for the efficacy of allergen‐free immunotherapy
ALLERGY, Vol. 70, Iss. 3, 2015-03 ,pp. :